Brief: Kaleido Biosciences Reports Third Quarter 2019 Financial Results And Provides Corporate Update

Kaleido Biosciences

30/10/2019 22:15

Oct 30 (Reuters) - Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES REPORTS THIRD QUARTER 2019 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * Q3 LOSS PER SHARE $0.74
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.89 -- REFINITIV IBES
DATA
    * EXECUTING PIPELINE TOWARDS KEY CLINICAL DATA READOUTS IN
Q4 2019
AND 2020
    * UNDERTAKING MEASURES TO EXTEND ITS CASH BY APPROXIMATELY A
QUARTER WITH RUNWAY INTO Q4 2020
    * KALEIDO BIOSCIENCES - MEASURES TO EXTEND CASH BY ABOUT
QUARTER
INCLUDES REDUCING HEADCOUNT BY APPROXIMATELY 25 PERCENT
    * AS OF SEPTEMBER 30, 2019, COMPANY REPORTED CASH AND CASH
EQUIVALENTS OF $81.3 MILLION

Source text for Eikon:  ID:nGNX9pbgnm 
Further company coverage:  KLDO.O 

 ((Reuters.Briefs@thomsonreuters.com;))